688073 毕得医药
已收盘 09-11 15:00:01
资讯
新帖
简况
9月10日毕得医药跌8.05%，大摩健康产业混合A基金重仓该股
证券之星 · 09-10 16:37
9月10日毕得医药跌8.05%，大摩健康产业混合A基金重仓该股
A股异动丨毕得医药大跌超8% 一致行动人股东合计减持2.50%股份
格隆汇 · 09-10 11:40
A股异动丨毕得医药大跌超8% 一致行动人股东合计减持2.50%股份
毕得医药(688073.SH)股东拟减持合计不超3%股份
智通财经 · 09-09 22:31
毕得医药(688073.SH)股东拟减持合计不超3%股份
毕得医药公告：控股股东及一致行动人拟于10月9日至次年1月8日期间合计减持不超过公司3.0%股份
美股速递 · 09-09 21:09
毕得医药公告：控股股东及一致行动人拟于10月9日至次年1月8日期间合计减持不超过公司3.0%股份
毕得医药：控股股东及一致行动人拟合计减持不超3.01%股份
格隆汇 · 09-09 21:06
毕得医药：控股股东及一致行动人拟合计减持不超3.01%股份
毕得医药（688073）披露2024年限制性股票激励计划首次及预留授予部分第一个归属期归属结果公告，9月8日股价上涨8.01%
证券之星 · 09-08
毕得医药（688073）披露2024年限制性股票激励计划首次及预留授予部分第一个归属期归属结果公告，9月8日股价上涨8.01%
9月8日毕得医药涨8.01%，大摩健康产业混合A基金重仓该股
证券之星 · 09-08
9月8日毕得医药涨8.01%，大摩健康产业混合A基金重仓该股
每周股票复盘：毕得医药（688073）发生大宗交易成交217.96万元
证券之星 · 09-06
每周股票复盘：毕得医药（688073）发生大宗交易成交217.96万元
每周股票复盘：毕得医药（688073）股东户数增23.07%，净利增40.73%
证券之星 · 08-30
每周股票复盘：毕得医药（688073）股东户数增23.07%，净利增40.73%
毕得医药(688073)6月30日股东户数0.61万户，较上期增加23.07%
证券之星 · 08-28
毕得医药(688073)6月30日股东户数0.61万户，较上期增加23.07%
图解毕得医药中报：第二季度单季净利润同比增长32.22%
证券之星 · 08-28
图解毕得医药中报：第二季度单季净利润同比增长32.22%
8月24日毕得医药跌7.68%，大摩健康产业混合A基金重仓该股
证券之星 · 08-24
8月24日毕得医药跌7.68%，大摩健康产业混合A基金重仓该股
每周股票复盘：机构净买入毕得医药（688073）281.81万元
证券之星 · 08-23
每周股票复盘：机构净买入毕得医药（688073）281.81万元
8月21日毕得医药现1笔大宗交易 机构净买入281.81万元
证券之星 · 08-21
8月21日毕得医药现1笔大宗交易 机构净买入281.81万元
8月20日毕得医药发生2笔大宗交易 成交金额451.71万元
证券之星 · 08-20
8月20日毕得医药发生2笔大宗交易 成交金额451.71万元
8月19日毕得医药跌11.51%，大摩健康产业混合A基金重仓该股
证券之星 · 08-19
8月19日毕得医药跌11.51%，大摩健康产业混合A基金重仓该股
每周股票复盘：毕得医药（688073）股东减持5%股份
证券之星 · 08-16
每周股票复盘：毕得医药（688073）股东减持5%股份
股市必读：毕得医药新发布《简式权益变动报告书》
证券之星 · 08-14
股市必读：毕得医药新发布《简式权益变动报告书》
8月13日毕得医药涨6.57%，大摩健康产业混合A基金重仓该股
证券之星 · 08-13
8月13日毕得医药涨6.57%，大摩健康产业混合A基金重仓该股
毕得医药收上交所监管工作函 中欧基金工银瑞信等持股
中金财经 · 08-13
毕得医药收上交所监管工作函 中欧基金工银瑞信等持股
加载更多
公司概况
公司名称：
上海毕得医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-10-11
主营业务：
上海毕得医药科技股份有限公司的主营业务是药物分子砌块和科学试剂的研发、设计、生产及销售。公司的主要产品是药物分子砌块、科学试剂。
发行价格：
88.00
{"stockData":{"symbol":"688073","market":"SH","secType":"STK","nameCN":"毕得医药","latestPrice":55.66,"timestamp":1789110001000,"preClose":58.58,"halted":0,"volume":4343008,"delay":0,"changeRate":-0.0498,"floatShares":90882900,"shares":90882900,"eps":1.9986,"marketStatus":"已收盘","change":-2.92,"latestTime":"09-11 15:00:01","open":58.18,"high":58.48,"low":54.54,"amount":242000000,"amplitude":0.0673,"askPrice":55.69,"askSize":2,"bidPrice":55.66,"bidSize":97,"shortable":0,"etf":0,"ttmEps":1.9986,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":5,"adr":0,"adjPreClose":58.58,"symbolType":"stock_kcb","openAndCloseTimeList":[[1789090200000,1789097400000],[1789102800000,1789110000000]],"highLimit":64.44,"lowLimit":52.72,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":90882948,"isCdr":false,"pbRate":2.45,"roa":"--","peRate":27.849495,"roe":"4.95%","epsLYR":1.75,"committee":0.490196,"marketValue":5059000000,"turnoverRate":0.0478,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-14。","afterMarket":{"amount":22264,"volume":400,"close":55.66,"buyVolume":0,"sellVolume":0,"time":1789112037746,"indexStatus":"已收盘 09-11 15:30:00","preClose":58.58},"floatMarketCap":5059000000},"requestUrl":"/m/hq/s/688073","defaultTab":"news","newsList":[{"id":"2666566288","title":"9月10日毕得医药跌8.05%，大摩健康产业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666566288","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666566288?lang=zh_cn&edition=full","pubTime":"2026-09-10 16:37","pubTimestamp":1789029444,"startTime":"0","endTime":"0","summary":"证券之星消息，9月10日毕得医药跌8.05%，收盘报58.58元，换手率6.28%，成交量5.71万手，成交额3.38亿元。重仓毕得医药的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为摩根士丹利基金的大摩健康产业混合A。大摩健康产业混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000029175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666554033","title":"A股异动丨毕得医药大跌超8% 一致行动人股东合计减持2.50%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2666554033","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666554033?lang=zh_cn&edition=full","pubTime":"2026-09-10 11:40","pubTimestamp":1789011632,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0216","688073","399300","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666539605","title":"毕得医药(688073.SH)股东拟减持合计不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2666539605","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666539605?lang=zh_cn&edition=full","pubTime":"2026-09-09 22:31","pubTimestamp":1788964282,"startTime":"0","endTime":"0","summary":"智通财经APP讯，毕得医药(688073.SH)发布公告，因自身资金需求，戴岚女士、戴龙先生、南煦投资、蓝昀万驰计划根据市场情况，于本减持计划披露之日起15个交易日后的3个月内通过集中竞价、大宗交易方式减持合计不超3%股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"毕得医药(688073.SH)股东拟减持合计不超3%股份","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195789195","title":"毕得医药公告：控股股东及一致行动人拟于10月9日至次年1月8日期间合计减持不超过公司3.0%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1195789195","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195789195?lang=zh_cn&edition=full","pubTime":"2026-09-09 21:09","pubTimestamp":1788959349,"startTime":"0","endTime":"0","summary":"毕得医药今日披露，公司控股股东及其一致行动人已制定减持计划。根据公告内容，这些股东预计在10月9日至1月8日的时间窗口内，合计减持公司股份比例最高可达3.0%。此举或将对市场情绪产生一定影响，投资者需密切关注后续动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666553551","title":"毕得医药：控股股东及一致行动人拟合计减持不超3.01%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2666553551","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666553551?lang=zh_cn&edition=full","pubTime":"2026-09-09 21:06","pubTimestamp":1788959180,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329402","title":"毕得医药（688073）披露2024年限制性股票激励计划首次及预留授予部分第一个归属期归属结果公告，9月8日股价上涨8.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329402","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665329402?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:53","pubTimestamp":1788861191,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，毕得医药报收于64.2元，较前一交易日上涨8.01%，最新总市值为58.35亿元。近日，上海毕得医药科技股份有限公司发布《关于2024年限制性股票激励计划首次授予及预留授予部分第一个归属期归属结果的公告》。公告显示，公司已完成2024年限制性股票激励计划首次授予及预留授予部分第一个归属期的股份登记，本次归属股票数量为111.2012万股，来源为公司从二级市场回购的A股普通股股票，归属对象共58名。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800027756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665325117","title":"9月8日毕得医药涨8.01%，大摩健康产业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665325117","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665325117?lang=zh_cn&edition=full","pubTime":"2026-09-08 16:39","pubTimestamp":1788856743,"startTime":"0","endTime":"0","summary":"证券之星消息，9月8日毕得医药涨8.01%，收盘报64.2元，换手率8.57%，成交量7.79万手，成交额4.82亿元。重仓毕得医药的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为摩根士丹利基金的大摩健康产业混合A。大摩健康产业混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800026112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665178365","title":"每周股票复盘：毕得医药（688073）发生大宗交易成交217.96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665178365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665178365?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:04","pubTimestamp":1788631454,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，毕得医药（688073）报收于58.59元，较上周的61.44元下跌4.64%。本周，毕得医药9月2日盘中最高价报61.8元。9月4日盘中最低价报58.03元。毕得医药当前最新总市值53.25亿元，在医疗服务板块市值排名32/51，在两市A股市值排名3046/5214。本周关注点交易信息汇总：9月4日毕得医药发生1笔大宗交易，成交金额217.96万元交易信息汇总9月4日毕得医药发生1笔大宗交易，成交金额217.96万元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663801053","title":"每周股票复盘：毕得医药（688073）股东户数增23.07%，净利增40.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663801053","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663801053?lang=zh_cn&edition=full","pubTime":"2026-08-30 01:55","pubTimestamp":1788026112,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，毕得医药报收于61.44元，较上周的71.6元下跌14.19%。业绩披露要点：归母净利润1.03亿元，同比上升40.73%。股本股东变化截至2026年6月30日，公司股东户数为6060.0户，较3月31日增加1136.0户，增幅23.07%。户均持股数量由1.85万股下降至1.5万股，户均持股市值为80.71万元。第二季度单季主营收入3.6亿元，同比上升8.58%；单季归母净利润5647.49万元，同比上升32.22%；单季扣非净利润4367.76万元，同比上升40.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000000619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662066393","title":"毕得医药(688073)6月30日股东户数0.61万户，较上期增加23.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662066393","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662066393?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:40","pubTimestamp":1787910046,"startTime":"0","endTime":"0","summary":"证券之星消息，近日毕得医药披露，截至2026年6月30日公司股东户数为6060.0户，较3月31日增加1136.0户，增幅为23.07%。在医疗服务行业个股中，毕得医药股东户数低于行业平均水平，截至6月30日，医疗服务行业平均股东户数为4.76万户。从股价来看，2026年3月31日至2026年6月30日，毕得医药区间跌幅为0.52%，在此期间股东户数增加1136.0户，增幅为23.07%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800040691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662885087","title":"图解毕得医药中报：第二季度单季净利润同比增长32.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662885087","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662885087?lang=zh_cn&edition=full","pubTime":"2026-08-28 02:02","pubTimestamp":1787853751,"startTime":"0","endTime":"0","summary":"证券之星消息，毕得医药2026年中报显示，上半年度公司主营收入6.83亿元，同比上升8.81%；归母净利润1.03亿元，同比上升40.73%；扣非净利润8360.22万元，同比上升41.31%；其中2026年第二季度，公司单季度主营收入3.6亿元，同比上升8.58%；单季度归母净利润5647.49万元，同比上升32.22%；单季度扣非净利润4367.76万元，同比上升40.49%；负债率17.18%，投资收益117.63万元，财务费用2103.58万元，毛利率50.42%。财报数据概要请见下图:本文数据来源于毕得医药2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800005531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661221236","title":"8月24日毕得医药跌7.68%，大摩健康产业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661221236","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661221236?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:32","pubTimestamp":1787560369,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日毕得医药跌7.68%，收盘报66.1元，换手率5.32%，成交量4.83万手，成交额3.26亿元。重仓毕得医药的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为摩根士丹利基金的大摩健康产业混合A。大摩健康产业混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400021808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661621166","title":"每周股票复盘：机构净买入毕得医药（688073）281.81万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661621166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661621166?lang=zh_cn&edition=full","pubTime":"2026-08-23 01:34","pubTimestamp":1787420052,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，毕得医药报收于71.6元，较上周的83.34元下跌14.09%。本周，毕得医药8月17日盘中最高价报83.0元。8月19日盘中最低价报69.66元。毕得医药当前最新总市值65.07亿元，在医疗服务板块市值排名30/51，在两市A股市值排名2557/5210。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661926444","title":"8月21日毕得医药现1笔大宗交易 机构净买入281.81万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661926444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661926444?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:27","pubTimestamp":1787308075,"startTime":"0","endTime":"0","summary":"证券之星消息，8月21日毕得医药发生大宗交易，交易数据如下：大宗交易成交价格64.45元，相对当日收盘价折价9.99%，成交4.37万股，成交金额281.81万元，买方营业部为机构专用，卖方营业部为浙商证券股份有限公司上海长乐路证券营业部。近三个月该股共发生25笔大宗交易，合计成交1.41万手，折价成交24笔，溢价成交1笔。本文数据来源于上海证券交易所大宗交易信息披露，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100034479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660882722","title":"8月20日毕得医药发生2笔大宗交易 成交金额451.71万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660882722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660882722?lang=zh_cn&edition=full","pubTime":"2026-08-20 17:56","pubTimestamp":1787219784,"startTime":"0","endTime":"0","summary":"证券之星消息，8月20日毕得医药发生大宗交易，交易数据如下：近三个月该股共发生24笔大宗交易，合计成交1.36万手，折价成交23笔，溢价成交1笔。该股在过去半年内已有共计4764.88万股限售解禁股上市，占公司总股本的52.43%。截至2026年8月20日收盘，毕得医药(688073)报收于74.91元，上涨6.29%，换手率8.35%，成交量7.59万手，成交额5.69亿元。该股近半年内有股东持股变动，合计净减持260.1万股，股东增减持明细如下表：该股最近90天内共有1家机构给出评级，买入评级1家。本文数据来源于上海证券交易所大宗交易信息披露，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000032589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660445787","title":"8月19日毕得医药跌11.51%，大摩健康产业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660445787","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660445787?lang=zh_cn&edition=full","pubTime":"2026-08-19 16:41","pubTimestamp":1787128867,"startTime":"0","endTime":"0","summary":"证券之星消息，8月19日毕得医药跌11.51%，收盘报70.48元，换手率7.92%，成交量7.2万手，成交额5.3亿元。重仓毕得医药的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为摩根士丹利基金的大摩健康产业混合A。大摩健康产业混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900028319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659175981","title":"每周股票复盘：毕得医药（688073）股东减持5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2659175981","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659175981?lang=zh_cn&edition=full","pubTime":"2026-08-16 01:29","pubTimestamp":1786814948,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，毕得医药报收于83.34元，较上周的61.6元上涨35.29%。交易信息汇总沪深交易所2026年8月10日公布，毕得医药因单日收盘价涨幅达15%及连续3个交易日内累计涨幅偏离值达30%，登龙虎榜。关于股东权益变动触及5%整数倍的提示性公告2026年1月28日至8月11日，上述三方合计减持毕得医药股份4,544,153股，占总股本5.00%，持股比例由10.00%降至5.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169615","title":"股市必读：毕得医药新发布《简式权益变动报告书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659169615?lang=zh_cn&edition=full","pubTime":"2026-08-14 01:02","pubTimestamp":1786640539,"startTime":"0","endTime":"0","summary":"关于股东权益变动触及5%整数倍的提示性公告2026年1月28日至8月11日，舟山兰旦企业管理合伙企业、舟山欣曦企业管理合伙企业及吴波通过大宗交易和集中竞价方式合计减持毕得医药股份4,544,153股，占公司总股本的5.00%；减持后合计持股比例由10.00%减少至5.00%；权益变动未违反已披露承诺，不触发强制要约收购义务，不会导致公司控股股东、实际控制人发生变化；相关方已履行减持计划的信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400000747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659270132","title":"8月13日毕得医药涨6.57%，大摩健康产业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2659270132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659270132?lang=zh_cn&edition=full","pubTime":"2026-08-13 16:36","pubTimestamp":1786610171,"startTime":"0","endTime":"0","summary":"证券之星消息，8月13日毕得医药涨6.57%创60日新高，收盘报84.83元，换手率10.51%，成交量9.55万手，成交额7.99亿元。重仓毕得医药的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为摩根士丹利基金的大摩健康产业混合A。大摩健康产业混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300026840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659134053","title":"毕得医药收上交所监管工作函 中欧基金工银瑞信等持股","url":"https://stock-news.laohu8.com/highlight/detail?id=2659134053","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659134053?lang=zh_cn&edition=full","pubTime":"2026-08-13 16:00","pubTimestamp":1786608006,"startTime":"0","endTime":"0","summary":"中国经济网北京8月13日讯 上交所网站昨日更新公告显示，毕得医药 于8月12日收到关于上海毕得医药科技股份有限公司相关事项的监管工作函。 公告显示，此次监管工作函的监管类型为“监管工作函”，涉及对象包括上市公司本身、公司董事、高级管理人员以及控股股东及实际控制人，处理事由为“关于上海毕得医药科技股份有限公司相关事项的监管工作函”，但未披露具体涉及的相关事项细节。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/13/20260813339021.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/13/20260813339021.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260813/32333933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","688073"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789198258689,"stockEarnings":[{"period":"1week","weight":-0.05},{"period":"1month","weight":-0.3008},{"period":"3month","weight":0.2066},{"period":"6month","weight":-0.0138},{"period":"1year","weight":-0.1455},{"period":"ytd","weight":-0.0664}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海毕得医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"6060人(较上一季度增加23.07%)","perCapita":"14997股","listingDate":"2022-10-11","address":"上海市杨浦区翔殷路128号11号楼A座101室","registeredCapital":"9088万元","survey":" 上海毕得医药科技股份有限公司的主营业务是药物分子砌块和科学试剂的研发、设计、生产及销售。公司的主要产品是药物分子砌块、科学试剂。","listedPrice":88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"毕得医药(688073)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供毕得医药(688073)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"毕得医药,688073,毕得医药股票,毕得医药股票老虎,毕得医药股票老虎国际,毕得医药行情,毕得医药股票行情,毕得医药股价,毕得医药股市,毕得医药股票价格,毕得医药股票交易,毕得医药股票购买,毕得医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"毕得医药(688073)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供毕得医药(688073)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}